Third Age Health Services Limited logo

Third Age Health Services - 1H FY26 Results

Half Year Results7 November 2025TAHConsumer Discretionary

Third Age Health delivers 1H26 Underlying NPATA
1

of $1,742k up 28%

and 14% on 1H25 and 2H25 respectively.

1H26 Business Highlights

• Services provided to 122 Aged Residential Care (“ARC”) facilities at the end of 1H26 up 35

YoY

2

.

o The number of ARC residents (patients) we provide care to has increased by 35.6%

YoY to 7,159 residents

o Excluding the two recent acquisitions the number of ARC residents we provide care

to has increased by 3.7% YoY

o The number of ARC residents we provide care to is estimated at 19.0% of the total

ARC population across NZ

3

.2

• Grew our combined enrolled patient population by 5% across both ARC and general practice

for 1H26 to 27,191 including new acquisitions when compared to YoY. Excluding acquisitions,

our combined enrolled patient population grew 2% with growth in ARC offset by a 2.4% YoY

decline in general practice enrolments.


Financial Highlights (unaudited) $'000

1H26 1H25 1H

change

2H25 2H

change`

Revenue 10,653 9,413 +13.2% 9,668 +10.2%

Underlying EBIT 2,539 2,053 +23.7% 2,216 +14.6%

EBIT Margin 23.8% 21.8% +2.0% 22.9% +0.9%

Underlying NPBTA

4

2,367 1,858 +27.4% 2,050 +15.5%

Underlying NPBTA% 22.2% 19.7% +2.5% 21.2% +1.0%

Underlying NPATA 1,742 1,361 +28.0% 1,525 +14.2%

Underlying NPATA% 16.4% 14.5% +1.9% 15.8% +0.6%





Statutory NPAT

1,520 1,154 +31.7% 1,324 +14.8%

Statutory NPAT%

14.3% 12.3% +2.0% 13.7% 0.6%

Diluted earnings per share

14.22 9.96 +4.26 12.49 +1.73

Ordinary dividends per share (cents) 8.00 6.83 +17.1% 7.88 +1.5%

Return on Equity (TTM)

62.9% 55.3% +7.6% 60.9% +2.0%

Return on Capital Employed (TTM)

41.5% 35.1% +6.4% 42.8% -1.3%



1H26 Financial Highlights (Unaudited)

• Group revenue up 13% YoY to $10,653k and 10% over 2H25 (1H25: $9,413k, 2H25: $9,668k).

• Revenue from ARC-related business up 20% YoY to $6,840k (1H25: $5,693k).

• Underlying NPBTA

3

up 27% YoY at $2,367k and 16% over 2H25 (1H25: $1,858k. 2H25:

$2,050k).


1

Underlying NPATA is adjusted for non-cash amortisation charges arising as a result of purchase accounting rules

2

YoY represents H1 FY26 compared to H1 FY25

3

Based on actual enrolment to 30 September 2025 and our latest estimates of ARC occupancy across New Zealand

according to Aged Care Association aged residential care occupancy report for 30 June 2025 quarter.

4

Underlying NPBTA is adjusted for non-cash amortisation charges arising as a result of purchase accounting rules.




• Underlying NPATA (adjusted for unaudited tax calculation) up 28% YoY to $1,742k and 14.2%

over 2H25 (1H25: $1,361k, 2H25: $1,525k).

• Statutory NPAT (adjusted for unaudited tax calculation) up 32% YoY to $1,520k and 14% over

2H25 (1H25: $1,154k, 2H25: $1,324K).


Dividend Declaration

We are pleased to announce a second quarter fully imputed dividend per share of 4.00 cents, in line

with our dividend policy. Combined with the dividend of 4.00 cents paid for the first quarter this

takes our total dividend declared for the 1H26 to 8.00 cents.


The board of directors of Third Age Health Services Limited has approved the release of this

document to the market.


About Third Age Health (NZX:TAH)

Third Age Health is New Zealand’s only specialised provider of general practice health care services

for older people living in retirement villages, private hospitals, secure dementia units as well as in

communities across New Zealand. A dedicated Third Age Health clinical team provides onsite clinics,

rostered rounds and after hours on-call healthcare services aimed at supporting the health and

wellbeing of older people to improve quality of life. As well as providing clinical services for over 120

aged care facilities throughout New Zealand, Third Age Health owns several general practices

providing quality primary healthcare to people of all ages.

www.thirdagehealth.co.nz

---

Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)


Updated as at March 2025


Results for announcement to the market

Name of issuer Third Age Health Services Limited

Reporting Period 6 months to 30 September 2025

Previous Reporting Period 6 months to 30 September 2024

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$10,653 13.2%

Total Revenue $10,653 13.2%

Net profit/(loss) from

continuing operations

$1,520 31.7%

Total net profit/(loss) $1,520 31.7%

Interim/Final Dividend

Amount per Quoted Equity

Security

$0.04000000

Imputed amount per Quoted

Equity Security

$0.01555556

Record Date 14 November 2025

Dividend Payment Date 2 December 2025

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security (in

dollars and cents per

security)

-$0.154 -$0.076

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

The movement in net tangible assets is the result of changes in the

Statement of Financial Position composition owing to the increase in

intangibles from the acquisition of ARC Health Limited and Cicada Health

Limited and the corresponding decrease in cash at bank also owing to this

purchase of these acquisitions. See Half Year financial statements for further

details.

Authority for this announcement

Name of person


authorised

to make this announcement

Geraldine Bromley

Contact person for this

announcement

Geraldine Bromley

Contact phone number 022 127 5598

Contact email address geraldineb@thirdagehealth.co.nz

Date of release through MAP


7 November 2025


Unaudited financial statements accompany this announcement.

---

INTERIM REPORT
INTERIM REPORT

For the six monthsended

30September 2025

John Fernandes
Executive Chairman

November 2025

On behalf of the Board and management of

Third Age Health, I am pleased to present the

Third Age Health Services Limited Interim Report

for the six months ended 30 September 2025.

CONTENTS

Executive Chairman Report

Interim Financial Statements

Notes to Financial Statements

3 - 4

5 - 10

11 - 27

Dear Shareholders,
During the first half, NPAT increased by 31.7% Yo Y

1

to $1,520k, while underlying NPATA

2

rose

28.0% Yo Y to $1,742k.

We also completed the acquisitions of ARC Health and Cicada Health which provide medical

services to aged residential care (“ARC”) facilities. ARC Health operates in Canterbury, and

Cicada Health in the Bay of Plenty. Their integration further strengthens our national network,

and we’re pleased that the founders of both businesses remain co-owners and continue to play

an active role.

Financial Performance

Our ARC-related business continues to grow with 7,159 enrolled patients at period end.

Excluding the two new acquisitions, organic enrolled patients grew 3.7% Yo Y to 5,475, and ARC

total revenue grew 20% to $6,840k. We continue to attract interest for our services from

additional ARC facilities, however growth during the period was constrained by the sector-wide

shortage of clinical workforce. This has required ongoing discipline and trade-offs. We are

spending more on workforce recruitment, development and digital enablement to support

sustainable growth over time.

Our community general practice business delivered further gains in financial performance.

Revenue rose 2.5% to $3,813k, and profitability also improved through ongoing process

improvements. Enrolled patient numbers declined 2.4% Yo Y to 20,032, driven by the residual

impact of a doctor departure earlier in the year, along with a doctor vacancy (now filled) at one

of our clinics. Reversing this trend is a key priority.

Creating Value for Our Customers

We continue to invest in initiatives that improve outcomes for our customers and make our

services more resilient.

Our Digital Clinical Portal continues to gain traction, with rollout now reaching over 30 facilities.

It has supported more than 900 scheduled rounds across multiple regions and customers.

Develop ment of Phase Two, which seeks to further improve operational efficiency, is well

underway and we have started planning for Phase Three.

We’ve also progressed our commitment to sector-leading quality care standards through the

development of the Residential Care Medical Service Provider Standard, or Elder Care

Standards. These standards have now been independently assessed by a designated auditing

agency

3

and rolled out to our clinicians. They reflect our goal of supporting more consistent,

high-quality aged care across the sector.

We were recently appointed as the sole preferred partner for medical services by the Aged Care

Association New Zealand. We see this as both a recognition of the work done to date and a

foundation for deeper collaboration. We value the opportunity to help advance outcomes for

the sector.

1

Ye a r-Over-Year i.e. 1H 2026 compared to 1H 2025

2

Net Profit After Tax before Amortisation is adjusted for non-cash amortisation charges arising as a result

of purchase accounting rules.

3

Organisations authorised by the Ministry of Health to audit health and disability service providers

against regulatory standards.

3

Business Unit Leadership
We are pleased to have appointed Niomi Fleming and Lucy Wu as Acting General Managers of

our ARC-related and community g eneral practice businesses respectively.

Niomi has led the day-to-day operations of our ARC business since joining us in 2022. She

brings over 15 years of experience in the primary care sector and is known for her focus on

delighting customers, strong operational discipline, and close relationships with clinicians.

Lucy has been our Clinical Change Lead since 2021 and brings first-hand experience as both a

general practice nurse and a programme lead. She has helped shape and deliver initiatives that

have improved operational performance and patient outcomes.

Our operating model is built on decentralised autonomy and accountability. This enables faster

decisions made closer to the front line, deeper customer engagement, and stronger support for

our teams. We’re pleased to see strong internal leaders step into these roles and are confident

in their ability to drive performance.

Capital Allocation

During the first half, we funded the acquisitions of ARC Health and Cicada Health through a

combination of cash on hand and a draw on our line of credit. The line has since been repaid.

These acquisitions were immediately accretive and have increased our earnings power.

Our goal is to maximise the average annual rate of increase in intrinsic value per share over

time. One of the ways we aim to achieve this is through allocating capital to acquiring good

businesses where our operating model built around decentralisation and Kaizen can deliver

strong results. This means businesses, both within and outside of healthcare, from owners

planning for their own third age. We offer a safe home for those wanting to entrust their business

to someone who will own it permanently, grow it carefully, and preserve its legacy.

Looking Ahead

Our focus remains on what’s within our control: delighting customers, running an organisation

grounded in Kaizen, aligning incentives and being frugal. We’re optimising for long-term

durability, and will continue to make choices that support that, even when they come with a

short-term cost.

We thank our team for their work and you, our fellow owners, for your trust.

Sincerely,

John F

ernandes

Executive Chairman

4

FINANCIAL STATEMENTS

Third Age Health Services Limited and subsidiaries
Condensed Consolidated Financial Statements

For the six months ended 30 September 2025


6



Approval and issue of Condensed Consolidated Financial Statements


The Directors are pleased to present the Condensed Consolidated Financial Statements of Third Age Health

Services Limited and its subsidiaries (the “Group’) for the six-months ended 30 September 2025.

The Board of Directors of the Group authorised the Condensed Consolidated Financial Statements, set out on

pages 7 to 27 for issue on 7 November 2025.






John Fernandes

Executive Chairman

Wayne Williams

Director and Audit Committee Chair



Third Age Health Services Limited and subsidiaries
Condensed Consolidated Statement of Comprehensive Income

For the six months ended 30 September 2025



7



30 September 2025 30 September 2024


(Unaudited) (Unaudited)


Notes $000 $000

Revenue 5

10,653 9,413

Cost of services 6 (5,258) (4,554)

Gross profit


5,395 4,859




Other income


23 30




Employees and contractors 8 (1,600) (1,673)

Professional and consulting fees 9 (320) (284)

Other expenses 10 (739) (679)

Operational expenses


(2,659) (2,636)




EBITDA


2,759 2,253




Amortisation and depreciation 11 (476) (407)

Finance costs 12 (138) (195)




Profit before income tax


2,145 1,651




Income tax expense


(625) (497)




Profit for the period


1,520 1,154




Other comprehensive income


- -




Total comprehensive income for the period


1,520 1,154




Profit and total comprehensive income attributable to:




Shareholders of the parent


1,415 1,026

Non-controlling interests


105 128




Profit for the period


1,520 1,154




Earnings per share (note 14)




Basic earnings per share (cents)


14.22 10.26

Diluted earnings per share (cents)


14.22 9.96





These consolidated financial statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited and subsidiaries
Condensed Consolidated Statement of Financial Position

As at 30 September 2025



8



30 September 2025 31 March 2025


(Unaudited) (Audited)

Notes $000 $000

Current assets


Cash and cash equivalents


1,579 2,594

Trade and other receivables 15 1,348 1,059

Other assets 209 104

Accrued revenue 43 40

Total current assets


3,179 3,797




Non-current assets



Property, plant and equipment


209 189

Right-of-use-assets 16 2,164 2,181

Intangible assets 17 7,077 4,773

Financial assets


20 20

Total non-current assets


9,470 7,163




Total assets


12,649 10,960

Current liabilities



Trade and other payables


2,539 1,882

Employee benefits 580 432

Provisions 22 22

Tax liabilities


382 648

Bank loan


90 59

Lease liabilities 16 354 330

Total current liabilities


3,967 3,373



Non-current liabilities



Bank loan 1,062 1,091

Other payables


- 6

Lease liabilities 16 2,074 2,094

Deferred tax liability


731 429

Total non-current liabilities


3,867 3,620



Total liabilities


7,834 6,993



Net assets


4,815 3,967

Equity



Share capital 20 485 485

Share based payment reserve


- 31

Retained earnings


3,946 3,326

Equity attributable to the parent


4,431 3,842




Non-Controlling Interests (NCI)


384 125



Total Equity


4,815 3,967


These consolidated financial statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited and subsidiaries
Condensed Statement of Changes in Equity

For the six months ended 30 September 2025



9



Share

capital

Share

based

payments

reserve

Retained

earnings

Non-

Controlling

Interest Total


Notes $000 $000 $000 $000 $000

Balance at 1 April 2024 (Audited)


596 657 1,704 (44) 2,913


Profit for the period


- - 1,026 128 1,154

Total comprehensive income for the period


- - 1,026 128 1,154


Dividend 21 - - (608) (29) (637)

Share buyback (2) - - - (2)

Share based payments


- 9 - - 9

NCI on acquisition - - - 206 206

Balance at 30 September 2024 (Unaudited)


594 666 2,122 261 3,643


Balance at 1 April 2025 (Audited)


485 31 3,326 125 3,967



Profit for the period


- - 1,415 105 1,520

Total comprehensive income for the period


- - 1,415 105 1,520



Dividend 21 (795) (97) (891)

Share buyback - - - - -

Share based payments - (31) - - (31)

NCI on acquisitions 18.2 - - - 250 250

Balance at 30 September 2025 (Unaudited)


485 - 3,946 384 4,815



















These financial statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited and subsidiaries
Condensed Statement of Cash Flows

For the six months ended 30 September 2025


10




30 September 2025 30 September 2024


(Unaudited) (Unaudited)


Notes $000 $000

Cash flows from operating activities


Receipts from customers


11,465 10,200

Payments to suppliers and employees


(8,788) (7,860)

Interest received


15 22

Interest paid


(124) (186)

Income taxes paid


(1,047) (643)

Net cash flows from operating activities 13 1,521 1,533




Cash flows from investing activities




Payments for property, plant and equipment


(33) (65)

Investment in developing intangible assets (108) (13)

Acquisition of businesses, net of cash acquired


(1,341) (571)

Net cash flows used in investing activities


(1,482) (649)




Cash flows from financing activities




Shares acquired - (2)

Proceeds from bank borrowing 19 607 598

Loan repayments on bank borrowing 19 (605) (729)

Payment of lease liabilities 16 (164) (150)

Dividend paid 21 (795) (608)

Dividend paid to NCI (97) (27)

Net cash flows (used in) / provided by financing

activities


(1,054) (918)




Net increase / (decrease) in cash and cash equivalents


(1,015) (34)



Cash and cash equivalents at the beginning of the

period


2,594 1,695

Cash and cash equivalents at the end of the period


1,579 1,661









These consolidated financial statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



11


1. Reporting Entity


The consolidated interim financial statements for Third Age Health Services Limited and its subsidiaries (the

"Group") are for the economic entity comprising Third Age Health Services Limited (the “Company” or

"Parent") and its subsidiaries. The Parent is incorporated and domiciled in New Zealand and registered under

the Companies Act 1993 and is a Financial Market Conduct (FMC) entity for the purposes of the Financial

Reporting Act 2013 and the Financial Markets Conduct Act 2013. The Financial Statements have been prepared

in accordance with each of these Acts. The Company is listed on the NZX Main Board ("NZX").


The Group is principally engaged in the provision of medical services to the aged care sector and in community

general practices. Those companies included in the Group are disclosed in note 18. These condensed

consolidated interim financial statements are for the 6 months ended 30 September 2025. The Group’s current

operations do not follow a seasonal or cyclical pattern.


2. Significant Accounting Policies


2.1. Statement of compliance and reporting framework


These unaudited condensed consolidated interim financial statements have been prepared in accordance with

New Zealand Generally Accepted Accounting Practice ("NZ GAAP"). They comply with the New Zealand

equivalent to International Accounting Standard 34 ("NZ IAS 34") Interim Financial Reporting. For the purposes

of complying with NZ GAAP, the Group is a for-profit entity.


The interim financial statements do not include all of the information required for full year financial

statements and should be read in conjunction with the Company's audited annual financial report for the year

ended 31 March 2025. Consistent accounting policies with the full financial statements for the year ended 31

March 2025 have been applied in preparation of these interim financial statements.


2.2. Basis of preparation


The consolidated interim financial statements for the six months ended 30 September 2025 and comparatives

for the six months ended 30 September 2024 are unaudited. The consolidated annual financial statements for

the year ended 31 March 2025 were audited and form the basis for the comparative figures for that period in

these statements.


The consolidated interim financial statements have been prepared in accordance with the going concern basis

of accounting, which assumes that the Group will be able to realise its assets and discharge its liabilities in the

normal course of business as they come due into the foreseeable future.


2.3. Use of accounting estimates and judgements


The preparation of the financial statements in conformity with NZ IAS 34 requires management to make

judgements, estimates and assumptions that affect the application of accounting policies and the reported

amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



12


The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates

are significant to the consolidated interim financial statements are as follows:


Fair value of assets acquired in business combinations

On 1 September 2025 Third Age Health Services Limited acquired an 80% share of ARC Health Limited, a

Canterbury based primary care provider to aged residential care facilities for a value of $1.1m.

In addition, on 1 September 2025 Third Age Health Services Limited acquired a 70% share of Cicada Health

Limited, a Bay of Plenty based primary care provider to aged residential care facilities for a value of $0.9m.

The consolidated financial statements are based on the Company’s best estimate at the date of preparation

owing to a proportion of the purchase price of each acquisition being deferred contingent consideration.


Carrying value of intangible assets

The Group has determined that no Cash Generating Units show indications of impairment.


3. Significant Events and Transactions


3.1 Acquisition of ARC Health Limited and Cicada Health Limited


On 1 September 2025 Third Age Health Services Limited acquired an 80% share of ARC Health Limited, a

Canterbury based primary care provider to aged residential care facilities for a value of $1.1m. In addition, on

1 September 2025 Third Age Health Services Limited acquired a 70% share of Cicada Health Limited, a Bay of

Plenty based primary care provider to aged residential care facilities for a value of $0.9m. Refer note 18.2 for

further details.


4. Net tangible assets


The Group has net tangible assets as at 30 September 2025 of (15.4) per share (31 March 2025 of (3.8)) cents

per share). The movement in net tangible assets is the result of changes in the Statement of Financial Position

composition owing to the increase in intangibles from the acquisition of ARC Health Limited and Cicada Health

Limited and the corresponding decrease in cash at bank owing to the purchases of these businesses.


5. Revenue


Revenue has been categorised as consultation revenue, capitation revenue and other revenue.


Consultation revenue

The Group earns revenue from the provision of medical consultation services. Each consultation performed is

a separate performance obligation satisfied at a point in time. The price for each consultation is a fixed amount

based on an agreed rate card with the customer. Revenue is recognised once the consultation service has been

provided. Revenue claims from contracts such as ACC and MOH (general medical, maternity and immunisation

claims) with customers are measured at the fair value of the consideration received or receivable and may be

reduced for rebates and other similar allowances.


Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



13


Capitation revenue

The Group provides various medical services on a ‘stand ready’ basis on behalf of Primary Health Organisations

(PHOs) and the company receives revenue known as “capitation” from the PHOs for this service. This

capitation revenue is recognised monthly based on the number of enrolled patients and the

agreed rate for the particular patient. The agreed rate will be affected by the characteristics of the patient, for

example, their age or gender. Revenue is recognised on a time lapsed basis.


Other income

Other income includes interest income. Interest revenue is recognised as interest accrues using the

effective interest method. This is a method of calculating the amortised cost of a financial asset and

allocating the interest income over the relevant period using the effective interest rate, which is the

rate that exactly discounts estimated future cash receipts through the expected life of the financial

asset to the net carrying amount of the financial asset.



30 September 2025 30 September 2024



(Unaudited) (Unaudited)



$000 $000

Capitation revenue


Aged medical care services


1,875 1,495

General practice medical services


2,138 2,042






Consultation revenue




Aged medical care services


4,909 4,113

General practice medical services


1,392 1,389





Other revenue




Aged medical care services


56 85

General practice medical services


283 289





Total revenue from contracts with customers


10,653 9,413



30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Total revenue from existing operations


10,404 8,680

Total revenue from acquired businesses


249 733


10,653 9,413


Total revenue from existing operations relates to businesses owned by the Group for over twelve months.

Total revenue from acquired businesses relates to businesses owned by the Group for under twelve months.


Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



14


6. Cost of services


Cost of services line include direct costs of doctors, nurses and medical supplies as well as other direct costs.




30 September 2025 30 September 2024



(Unaudited) (Unaudited)



$000 $000

Practitioners (GP’s and nurses)


5,127 4,423

Defined contribution (KiwiSaver)

12 16

Medical supplies

119 115

Total cost of services


5,258 4,554


30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Total cost of services from existing operations


5,110 4,204

Total cost of services from acquired businesses


148 350


5,258 4,554

7. Segment Information


Products and services from which reportable segments derive their revenue


The Group's reportable segments are as follows:

• Aged medical care services, being the provision of medical care services to the aged care sector.

• General practice medical services, being the provision of general medical care services to the community.


Segment revenues and profit before tax


The following is an analysis of the Group’s revenue and results from continuing operations by reportable

segment:


30 September 2025 30 September 2024

Segment revenue


(Unaudited) (Unaudited)


$000 $000

Aged medical care services


6,840 5,693

General practice medical services


3,813 3,720

Total for continuing operations


10,653 9,413



Segment profit before tax

30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Aged medical care services

1,634 1,322

General practice medical services

511 329

Total for continuing operations

2,145 1,651



Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



15


Segment profit includes the following items:

For the six months ended 30 September 2025


Aged care General practice



medical services medical services



$000 $000

EBITDA


1,781 978

Depreciation


(26) (194)

Amortisation of intangibles


(94) (162)

Interest expense on leases


(1) (86)

Interest on bank Loan


(2) (49)

Profit before tax


1,658 487




Income tax expense


(508)

(117)

Profit for the period


1,150 370



For the six months ended 30 September 2024 Aged care General practice


medical services medical services


$000 $000

EBITDA

1,396 857

Depreciation

(6) (194)

Amortisation of intangibles

(44) (163)

Interest expense on leases

- (96)

Interest on bank Loan

(24) (75)

Profit before tax

1,322 329




Income tax expense

(413)

(84)

Profit for the period

909 245


EBITDA represents profit before tax excluding amounts for depreciation and amortisation expenses, interest

expenses.


Segment profit before tax for the general practice medical services in 2025 includes $86k of finance costs from

the ANZ loan facility (note 12). This cost is allocated to this segment, as the loan facility was utilised to fund the

acquisition of general practices.


Segment assets and liabilities



30 September 2025

31 March 2025

Segment assets


(Unaudited)

(Audited)



$000 $000

Aged medical care services incl support functions


6,884 4,091

General practice medical services


7,113 8,416

Total segment assets


13,997 12,507



Intercompany elimination


(1,346) (1,547)

Total segment assets


12,651 10,960


Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



16



30 September 2025

31 March 2025

Segment liabilities


(Unaudited)

(Audited)



$000 $000

Aged medical care services incl support functions


4,073 3,200

General practice medical services


5,107 5,340

Total segment liabilities


9,180 8,540




Intercompany elimination


(1,346) (1,547)

Total segment liabilities


7,834 6,993


8. Employees and contractors



30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Salaries and wages


1,393 1,335

Short term incentives


60 148

Defined contribution (KiwiSaver)


68 71

Share based payments expense


(36) 9

Employee benefit expense


1,485 1,563





Contractors


115 110



1,600 1,673


Due to an employee departure, which resulted in the forfeiture of share options, the Group has reversed all

previously accrued share-based payment expenses and related short-term incentive accruals for that

employee.


Total employee costs are split between costs associated with operations that existed in the prior period and

new acquisitions.



30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Existing operations


1,589 1,673

New acquired subsidiaries


11 -


1,600 1,673


9. Professional and consulting fees


30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Fees payable to auditor

38 65

Accounting and taxation services

20 30

Legal expenses

111 33

Directors' fees

90 90

Listing and share registry costs

24 20

Other consultancy costs

37 46


320 284

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



17


10. Other expenses


30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Technology / IT 383 341

Marketing & PR 9 17

Travel & Entertainment 24 17

Professional operational services 118 94

Office and General 205 210


739 679


Total other expenses are split between costs associated with operations that existed in the prior period and

new acquisitions.




30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Other expenses from existing operations

732 672

Other expenses from acquired businesses

7 7


739 679



11. Amortisation and depreciation



30 September 2025 30 September 2024



(Unaudited) (Unaudited)



$000 $000

Depreciation on right of use assets


184 182

Depreciation on plant, property and equipment


36 18

Amortisation of acquisition-related intangibles


222 201

Amortisation of software


34 6



476 407



12. Finance costs


30 September 2025 30 September 2024



(Unaudited) (Unaudited)



$000 $000

Interest expense on leases


87 96

Interest on bank loan


51 99



138 195


Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



18


13. Reconciliation of profit before tax to net cash from operating activities



30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Profit before income tax 2,145 1,651




Adjustments to reconcile profit before tax to net cash flows:


Depreciation and amortisation 220 200

Amortisation of intangibles 256 207

Share based payments expense (31) 9

Other non-cash adjustments (1) 7







Working capital adjustments:


(Increase)/decrease in trade and other receivables (289) (241)

(Increase)/decrease in other assets (107) (87)

(Increase)/decrease in accrued revenue (3) 70


Increase/(decrease) in trade and other payables 651 351

Increase/(decrease) in employee benefits 148 116


Non-operating working capital adjustment (415) (124)

Impact of working capital acquired (6) 18


2,568 2,177

Income tax paid (1,047) (643)




Net cash from operating activities 1,521 1,533



14. Earnings per share


Basic earnings per share is calculated by dividing the profit attributable to the shareholders of the parent by

the weighted average number of ordinary shares outstanding during the period ending 30 September 2025,

excluding treasury shares.


Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take

into account the after-income tax effect of interest and other financing costs associated with dilutive potential

ordinary shares, and the weighted average number of ordinary shares that would have been outstanding

assuming the conversion of all dilutive potential ordinary shares.


Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



19


Reconciliation of earnings used in calculating earnings per share


30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000 $000

Net profit attributable to the ordinary shareholders of the

Group

1,415 1,026

Earnings used in the calculation of basic earnings per share 1,415 1,026


Weighted average number of shares used as the denominator


Shares Shares


000's 000's

Weighted average number of ordinary shares used as the

denominator in calculating basic earnings per share

9,955 10,003



Adjustments for calculation of diluted earnings per share:


Employee share options -

300



Weighted average number of ordinary shares and potential

ordinary shares used as the denominator in calculating diluted

earnings per share

9,955 10,303



From continuing operations:

Cents per share Cents per share

Basic earnings per share 14.22 10.26

Diluted earnings per share 14.22 9.96


The 30 September 2024 comparative has been adjusted to reflect employee share options previously not

accounted for.


15. Trade and other receivables


Current


30 September 2025 31 March 2025


(Unaudited) (Audited)



$000 $000

Trade receivables


1,399 1,107

Less provision for doubtful debts


(62) (59)



1,337 1,048


Other receivables 11 11


1,348 1,059


As at 30 September 2025 92% of the Group's trade receivables are current (31 March 2025: 94%). Short-term

receivables from customers (excluding Health NZ funding) are recorded at the amount due, less an allowance

for Expected Credit Losses (ECL). This allowance is calculated using a simplified approach based on a lifetime

ECL. The recorded provision in the reporting period is immaterial.




Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



20



Expected credit loss rate Carrying amount Allowance for expected

credit losses


30 September

2025

31 March

2025

30 September

2025

31 March

2025

30 September

2025

31 March

2025


(Unaudited) (Audited) (Unaudited) (Audited) (Unaudited) (Audited)


$000 $000 $000 $000 $000 $000

Current (<30 days) 0% 0% 1,283 1,035 4 1

30 to 60 days 15% 31% 32 15 5 5

30 to 60 days 15% 74% 33 11 5 5

Over 90 days 80% 98% 51 46 47 45

1,399 1,107 62 59


16. Right of use assets and lease liabilities


The following tables show the movement in right of use assets and lease liabilities.


Movements in the amounts recognised in the statement of financial position as at 30 September 2025 and the

prior corresponding period:


Right-of-use-asset


30 September 2025 31 March 2025


(Unaudited) (Audited)


$000 $000

Opening balance at beginning of period (Audited)

2,181 2,514

Additions

155 -

Lease reassessments

12 29

Depreciation

(184) (362)

Closing balance

2,164 2,181


Lease liabilities


30 September 2025 31 March 2025


(Unaudited) (Audited)


$000 $000

Opening balance at beginning of period (Audited)

2,424 2,705

Additions

156 -

Lease reassessments

12 27

Interest

87 185

Lease repayments

(251) (493)

Closing balance

2,428 2,424




Current

354 330

Non-current

2,074 2,094


2,428 2,424


Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



21


Amounts recognised in the Condensed Consolidated Statement of Comprehensive Income in the 6 months

ending 30 September 2025:


30 September 2025 30 September 2024


(Unaudited) (Unaudited)


$000

$000

Depreciation of right-of-use assets property

184 182

Interest expense (included in finance cost)

86 96

Short term office rent (included in office & general)

54 55


The total cash outflow for leases in the 6-month period ended September 2025 was $250k (2024: $245k).

The future minimum rentals payable under non-cancellable operating leases are $605k (2024: $1,115k).


17. Intangibles


30 September 2025 31 March 2025


(Unaudited) (Audited)



$000 $000

Goodwill


3,208 2,078

Intangibles


3,869 2,540



7,077 4,773


17.1 Goodwill


Goodwill arising on an acquisition of a business is carried at cost as established at the date of acquisition of the

business less accumulated impairment losses, if any.



30 September 2025 31 March 2025


(Unaudited) (Audited)



$000 $000

Opening balance


2,078 1,651

Additions from acquisitions


1,130 427

Closing balance


3,208 2,540




Goodwill impairment


- -




Net carrying amount of goodwill


3,208 2,540




As at 30 September 2025 goodwill related to the age medical care services segment was $1,557k (31 March

2025: $427k) and goodwill related to the general practice medical services was $1,651k (31 March 2025:

$1,651k).

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



22



18. Business combinations


18.1 Group composition


The parent entity is Third Age Health Services Limited, a company incorporated in New Zealand. The Group

had the following subsidiaries as of 30 September 2025. The current reporting period includes results from

new subsidiaries that were not part of the group for the same period last year.


Subsidiary name Country of

incorporation

30 September 2025

Ownership

31 March 2025

Ownership

Hawkes Bay Wellness Centre Limited New Zealand

100% 100%

Belmont Medical Centre Limited New Zealand

100% 100%

Ponsonby Medical (Third Age Health) Limited New Zealand

100% 100%

Devonport Family Medicine (Third Age Health) Limited

EastMed St Heliers Limited

New Zealand

New Zealand

100%

67%

100%

67%

Hub Aged Care Limited New Zealand

70% 70%

ARC Health Limited (acquired 1 September 2025) New Zealand

80% -

Cicada Health Limited (acquired 1 September 2025) New Zealand

70% -

ARC Holdings (Third Age Health) Limited (incorporated 25

August 2025)

New Zealand

100% -




18.2 Acquisitions


On 1 September 2025 Third Age Health Services Limited acquired an 80% share of ARC Health Limited (ARC

Health), a Canterbury based primary care provider to aged residential care facilities. In addition, on 1

September 2025 Third Age Health Services Limited acquired a 70% share of Cicada Health Limited (Cicada), a

Tauranga based primary care provider to aged residential care facilities. The acquisitions support Third Age

Health Services Limited’s future growth strategy in the Canterbury and Tauranga regions, an essential part of

expanding our national coverage and continuing to develop the model of healthcare for older people.

The complete results of the companies since their acquisition have been included in these Consolidated

Financial Statements for the period ended 30 September 2025, contributing $137k (Cicada) and $112k (ARC

Health) to Group revenues and $29k (Cicada) and $72k (ARC Health) to Group EBITDA. Prior to acquisition,

these businesses operated on a cash accounting basis. Therefore, owing to a lack of comparable IFRS-specific

data as well as timing between acquisition and half year reporting, a pro-forma profit or loss information of

the combined entities for the six months of FY26 owing is not provided.

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



23


Provisional purchase price allocation

Details of the fair value of identifiable assets and liabilities acquired, purchase consideration and goodwill are

as follows:


Cicada Heath Limited ARC Health Limited


$000 $000

Cash and expected working capital adjustment 677 868

Contingent consideration at fair value 183 234

Total fair value of consideration transferred

860 1,102

Fair value of NCI on acquisition

99 151

Current assets


Cash and receivables

122 94

Trade receivables

108 111

Prepayments

- 22

Non-current assets


Property, plant and equipment

- 23

Intangible assets (excluding goodwill)

422 888

Total assets acquired

652 1,138




Cicada Heath Limited ARC Health Limited


$000 $000

Current liabilities


Trade and other liabilities

(68) -

Accrued expenses

(78) (42)

GST and income tax

(59) (94)

Non-current liabilities


Deferred tax liability on intangibles

(118) (249)

Total liabilities acquired

(323) (385)

Total net assets acquired

329 753

Goodwill

630 500


ARC Health Limited (ARC Health)

For ARC Health total nominal consideration transferred or to be transferred to the vendors is as follows:

• $820,281 in cash paid on 1 September 2025.

• $48,269 current estimate of cash to be paid as a working capital adjustment.

• $280,000 in deferred contingent consideration considered payable on 1 September 2026, if certain

conditions are met (discussed below).


The $280,000 in total deferred contingent consideration is payable to the vendors if the following conditions

are met:

o The patient numbers after 12 months are the same or greater than the forecast confirmed and

agreed by the parties.

o EBIT is greater than the normalised EBIT agreed during due diligence.

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



24


The fair value of the deferred consideration under IFRS 13 has been calculated using a net present value

calculation at an appropriate discount rate. No risk portion calculation is deemed necessary. The fair value of

the $280,000 deferred contingent consideration is $233,997. The total difference of $46,003 interest expense

is recorded over one year and expensed monthly until 1 September 2026.


The total fair value of all consideration is $1,102,547.


The $820,281 cash paid was fully financed through working capital of the Group.


The expenses relating to the acquisition of ARC Health are the following:


• $24,159 in legal fees have been included in the Condensed Consolidated Statement of

Comprehensive Income in the 6 months ending 30 September 2025 (note 9).

• $46,003 in interest costs over 12 months from discounting the contingent consideration payable 1

September 2025 to fair value at acquisition date. $3,834 in interest costs have been included in the

Condensed Consolidated Statement of Comprehensive Income in the 6 months ending 30 September

2025 (note 12).


At acquisition date the company held trade receivables with a book and fair value of $110,798. All contracted

cash flows were expected to be collected on all receivables and no bad debts were recorded.


An assessment of goodwill is tested for impairment annually, or more frequently when there is an indication

that the unit may be impaired. The goodwill recognised will not be deductible for tax purposes.

Goodwill arises on the acquisition of subsidiaries. Goodwill represents the excess of the purchase

consideration over the fair value of the net identifiable tangible and intangible assets at the time of

acquisition. Management has used its past established experience of sales growth and synergistic savings to

determine their expectations for the future. The goodwill incorporates the expected synergies from local

knowledge and contacts with our national know-how and proven best practice. Deferred tax liability of 28% on

intangible assets is calculated at the time of acquisition, the minority interest portion is considered immaterial.


The value of the NCI is based on the fair value of net identifiable assets acquired based on the portion of net

identifiable assets owned by the NCI.

With this method, we have included the intangibles recognised on consolidation which cannot be recognised

in the separate financial statements (PHO Contract and Customer Relationships). The total NCI of $150,711 is

made up on the following:

• 20% of the book value of all the net balance sheet assets as at 30 September 2025 (20% of $113,884)

• 20% of the customer relationships calculated above (20% of $617,175)

• 20% of the PHO contract calculated above (20% of $271,255)

• 20% of deferred tax liability on intangibles (20% of ($248,760))

Cicada Health Limited (Cicada)


For Cicada total nominal consideration transferred or to be transferred to the vendors is as follows:

• $607,150 in cash paid on 1 September 2025.

• $70,311 current estimation of cash to be paid as a working capital adjustment being 100% of net

August receivables collected after acquisition date per the sale and purchase agreement.

• $218,750 in deferred contingent consideration considered payable on 1 September 2026, if certain

conditions are met (discussed below).

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



25


The $218,750 in total deferred contingent consideration is payable to the vendors if 12 months EBIT is over the

normalised EBIT agreed during due diligence.


The fair value of the deferred consideration under IFRS 13 has been calculated using net present value at an

appropriate discount rate. No risk portion calculation is deemed necessary. The fair value of the $218,750

deferred contingent consideration is $182,810. The total difference of $35,940 interest expense is recorded

over 1 year expensed monthly until 1 September 2026.


The total fair value of all consideration is $860,271.


The $607,150 cash paid was financed via a draw on our line of credit.


The expenses relating to the acquisition of Cicada are the following:


• $22,904 in legal fees have been included in the Condensed Consolidated Statement of

Comprehensive Income in the 6 months ending 30 September 2025 (note 9).

• $35,940 in interest costs over 12 months from discounting the contingent consideration payable 1

September 2025 to fair value at acquisition date. $2,995 in interest costs have been included in the

Condensed Consolidated Statement of Comprehensive Income in the 6 months ending 30 September

2025 (note 12).


At acquisition date the company held trade receivables with a book and fair value of $107,949. All contracted

cash flows were expected to be collected on all receivables and no bad debts were recorded.


An assessment of goodwill is tested for impairment annually, or more frequently when there is an indication

that the unit may be impaired. The goodwill recognised will not be deductible for tax purposes.

Goodwill arises on the acquisition of subsidiaries. Goodwill represents the excess of the purchase

consideration over the fair value of the net identifiable tangible and intangible assets at the time of

acquisition. Management has used its past established experience of sales growth and synergistic savings to

determine their expectations for the future. The goodwill incorporates the expected synergies from local

knowledge and contacts with our national know-how and proven best practice. Deferred tax liability of 28% on

intangible assets is calculated at the time of acquisition, the minority interest portion is considered immaterial.


The value of the NCI is based on the fair value of net identifiable assets acquired based on the portion of net

identifiable assets owned by the NCI.

With this method, we have included the intangibles recognised on consolidation which cannot be recognised

in the separate financial statements (PHO Contract and Customer Relationships). The total NCI of $98,709 is

made up on the following:

• 30% of the book value of all the net balance sheet assets as at 30 September 2025 (30% of $24,957)

• 30% of the customer relationships calculated above (30% of $279,310)

• 30% of the PHO contract calculated above (30% of $143,002)

• 30% of deferred tax liability on intangibles (30% of ($118,248))


Both ARC Health and Cicada acquisitions have working capital adjustments and deferred consideration

included in their sale and purchase agreements. Whilst initial accounting has been completed for the period

ending 30 September, these amounts are subject to change up to and including 12 months after acquisition

consistent with IFRS 3 business combinations.

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



26


Hub Aged Care Limited


On 1 April 2024, a 70% share of Hub Aged Care Limited was acquired including deferred consideration payable

one year later. In April 2025 it was deemed that the performance metrices required for a full payout in the

deferred consideration for the acquisition of Hub Aged Care Limited had been reached as per the sale and

purchase agreement. A $130k payment was made in April 2025 to the vendor consistent with our reporting in

our audited consolidated annual financial statements for the year ending 31 March 2025.


19. Bank loan


On 1 September 2025, a $607k loan drawdown was completed for the purchase of Cicada Health Limited.

During the period ended 30 September 2025, a total of $605k was repaid to reduce the principal amounts of

our bank loans including the loan related to Cicada Health Limited. Total interest charged on total loans in the

period was $51k (2024: $99k). The Group has complied with banking covenants for the period ending 30

September 2025.


20. Share capital


All ordinary shares rank equally with one vote attached to each fully paid share. Total issued share capital is

9,954,491 ordinary shares (2025: 9,954,491).


21. Dividend paid during the period


Dividends declared and paid during six-month period ended 30 September 2025:

Cents per share $000

Final dividend for the year ended 31 March 2025

3.98

398

Interim dividend (Quarter 1)

4.00

396



795




Dividends declared and paid during six-month period ended 30 September 2024:

Cents per share $000

Final dividend for the year ended 31 March 2024

2.80

280

Interim dividend (Quarter 1)

3.28

328



608


From the beginning of FY26 the Board adopted an updated dividend policy, moving from a payout ratio to a

fixed quarterly dividend of 4 cents per share to provide shareholders with greater certainty of regular returns

while retaining flexibility to reinvest for growth.

Third Age Health Services Limited and subsidiaries
Notes to the condensed consolidated financial statements

For the six months ended 30 September 2025



27


22. Related party transactions


Transactions with related parties


Name of related party Nature of relationship Transaction

30 September 2025 30 September 2024


(Unaudited) (Unaudited)

$000 $000

John Fernandes Director & Shareholder Director fees 31 31

Bevan Walsh Director & Shareholder Director fees 18 18

Wayne Williams Director & Shareholder Director fees 23 23

Steffan Crausaz Director & Shareholder Director fees 19 19



Directors’ fees for John Fernandes, Steffan Crausaz and Wayne Williams for the period ended 30 September

2025 also include fees as members of the Audit Committee. Wayne Williams, Chairman of the Audit

Committee, received a fee of $5,000, John Fernandes received a fee of $1,250 and Steffan Crausaz a fee of

$1,250.


23. Subsequent event


Interim dividend declared


After the period end, the Board have declared a fully imputed interim dividend (Quarter 2) of 4.00 cents per

share in line with its dividend policy.


Third Age Health Services Ltd
P O Box 303 387, North Harbour

Auckland 0751

thirdagehealth.co.nz

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.